(Q45788449)

16 December 2017

title

Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus (English)

1 reference

16 December 2017

1 reference

Donnelly JJ

1

1 reference

16 December 2017

Friedman A

2

1 reference

16 December 2017

Martinez D

3

1 reference

16 December 2017

Montgomery DL

4

1 reference

16 December 2017

Shiver JW

5

1 reference

16 December 2017

Motzel SL

6

1 reference

16 December 2017

Ulmer JB

7

1 reference

16 December 2017

Liu MA

8

1 reference

16 December 2017

language of work or name

English

0 references

publication date

1 June 1995

1 reference

16 December 2017

published in

Nature Medicine

1 reference

16 December 2017

volume

1

1 reference

16 December 2017

page(s)

583-587

1 reference

16 December 2017

issue

6

1 reference

16 December 2017

https://scigraph.springernature.com/pub.10.1038/nm0695-583

exact match

0 references

cites work

Heterologous protection against influenza by injection of DNA encoding a viral protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Heterologous and homologous protection against influenza A by DNA vaccination: optimization of DNA vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Gene inoculation generates immune responses against human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Bovine herpesvirus 1: immune responses in mice and cattle injected with plasmid DNA.

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Vaccination with a plasmid vector carrying the rabies virus glycoprotein gene induces protective immunity against rabies virus.

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Comparison of 10 influenza A (H1N1 and H3N2) haemagglutinin sequences obtained directly from clinical specimens to those of MDCK cell- and egg-grown viruses

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community.

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Use of single-gene reassortant viruses to study the role of avian influenza A virus genes in attenuation of wild-type human influenza A virus for squirrel monkeys and adult human volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Evaluation of Commercially Prepared Vaccines for Experimentally Induced Type A/New Jersey/8/76 Influenza Virus Infections in Mice and Squirrel Monkeys

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Lessons for human influenza from pathogenicity studies with ferrets

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Comparison of live, attenuated H1N1 and H3N2 cold-adapted and avian-human influenza A reassortant viruses and inactivated virus vaccine in adults

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Influenza: its control in persons and populations

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Temperature-Sensitive Mutants of Influenza Virus. III. Further Characterization of the ts-1[E] Influenza A Recombinant (H3N2) Virus in Man

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Efficacy of inactivated influenza A virus (H3N2) vaccines grown in mammalian cells or embryonated eggs

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Immune response of human volunteers and animals to vaccination with egg-grown influenza A (H1N1) virus is influenced by three amino acid substitutions in the haemagglutinin molecule

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Neutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Vaccinia recombinants as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Gene therapy by intramuscular injection of plasmid DNA: studies on firefly luciferase gene expression in mice

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Evaluation of the infectivity, immunogenicity, and efficacy of live cold-adapted influenza B/Ann Arbor/1/86 reassortant virus vaccine in adult volunteers

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Active immunization against virus infections due to antigenic drift by induction of crossreactive cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Influenza A subtype cross-protection after immunization of outbred mice with a purified chimeric NS1/HA2 influenza virus protein

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Safety and immunogenicity of a recombinant protein influenza A vaccine in adult human volunteers and protective efficacy against wild-type H1N1 virus challenge

1 reference

https://api.crossref.org/works/10.1038%2FNM0695-583

7 January 2021

Identifiers

DOI

10.1038/NM0695-583

1 reference

16 December 2017

Dimensions Publication ID

0 references

1 reference

16 December 2017